期刊文献+

大鼠活体内Luciferase标记骨髓间充质干细胞生物发光示踪监测 被引量:3

In vivo monitoring of luciferase labeled bone marrow mesenchymal stem cells by bioluminescent in rats
下载PDF
导出
摘要 目的应用生物发光技术监测同种异体骨髓间充质干细胞(bone marrow mesenchymal stem cells,BMSC)在健康大鼠体内的定植与动态分布情况。方法 Wistar大鼠BMSC经稳定表达增强绿色荧光蛋白(enhanced green fluorescent protein,e-GFP)和荧光素酶(luciferase)基因的慢病毒感染后,经尾静脉注射植入Wistar大鼠体内,通过活体成像连续监测其动态分布。结果活体成像结果显示,植入感染病毒的骨髓间充质干细胞(Luc-GFP-BMSC)1.5 h后在大鼠体内生物信号最强,主要聚集在肺,24 h后背部信号增强并居于主导,第3天胸部信号检测不到,14 d后,全身生物信号消失。结论同种异体大鼠BMSC经尾静脉植入后,首先聚集于肺部,弥散分布于背部,最终信号逐渐消失,提示经尾静脉注射植入可能是BMSC治疗肺部疾病的有效途径。 Objective To monitor the colonization and dynamic distribution of allogeneic bone marrow mesenchymal stem cells(BMSC) in healthy rats by using the technique of bioluminescent imaging. Methods BMSC from Wistar rat were infected by lentiviral which carry stable expression genes of luciferase and green fluorescence protein(Luc-GFP-BMSC), then implanted into Wistar rats by tail vein injection. Dynamic distribution of Luc-GFP-BMSC in rats was continuously monitored by using in vivo imaging system. Results In vivo imaging results showed that biological signal was strongest at 1.5 hours after implantation of Luc-GFP-BMSC in rats, and mainly resided in the lung, 24 hours later, signal in the back gradually enhanced and became dominant, after 3 days, signal in the chest couldn't be detected, after 14 days, biological signal in the whole body disappeared. Conclusions After implantation through the tail vein, allogeneic BMSC in healthy Wistar rats initially reside in the lungs, and then egress to the back, finally the biological signal gradually disappeared, which suggests that tail vein injection of BMSC may be an effective approach for lung disease.
出处 《中华灾害救援医学》 2016年第1期12-16,共5页 Chinese Journal of Disaster Medicine
基金 天津市科技计划项目(14ZCDZSY00033)
关键词 骨髓间充质干细胞 生物发光 活体成像 慢病毒 bone marrow mesenchymal stem cell bioluminescent imaging in vivo imaging lentiviral
  • 相关文献

参考文献22

  • 1Introna M, Lucchini G, Dander E, et al. Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients [J]. Biol Blood Marrow Transplant, 2014, 20 ( 3 ) : 375-381.
  • 2Resnick I B, Barkats C, Shapira M Y, et al. Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC) [J]. Am J Blood Res, 2013, 3 ( 3 ) :225-238.
  • 3Bartunek J, Behfar A, Dolatabadi D, et al. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardio- poietic stem Cell therapy in heart failure) multicenter randomized trial with lineage-specified biologics [J]. J Am Coil Cardiol, 2013, 61 ( 23 ) : 2329-2338.
  • 4Forostyak S, Jendelova P, Sykova E. The role of mesenchy- mal stromal cells in spinal cord injury, regener-ative medicine and possible clinical applications [J]. Biochimie, 2013, 95 ( 12 ) : 2257-2270.
  • 5Karamouzian S, Nematollahi-Mahani S N, Nakhaee N, et al. Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients [J]. Clin Neurol Neurosurg, 2012, 114 ( 7 ) : 935-939.
  • 6Amer M E, E1-Sayed S Z, E1-Kheir W A, et al. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte- like cells [J]. Eur J Gastroenterol Hepatol, 2011, 23 ( 10 ): 936-941.
  • 7Skrahin A, Ahmed R K, Ferrara G, et al. Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial [J]. Lancet Respir Med, 2014, 2 ( 2 ) : 108-122.
  • 8Wilson J G, Liu K D, Zhuo H, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial [J]. Lancet Respir Med, 2015, 3 ( 1 ) : 24-32.
  • 9Meleshina A V, Cherkasova E I, Shirmanova M V, et al. Influence of mesenchymal stem cells on metastasis development in mice in vivo [J]. Stem Cell Res Ther, 2015, 6( 1 ): 1-10.
  • 10Aanstoos M E, Regan D P, Rose R J, et al. CORR Insights~: Do mesenchymal stromal cells influence microscopic residual or metastatic osteosarcoma in a murine model? [J/OL]. Clin Ortho Relat Res, 2015: 1-9 [2015-10-26]. http://www.ncbi.nlm.nih.gov/ pubmed/26105153. [published online ahead of print Jun 24, 2015.].

二级参考文献16

  • 1Lukashev ME,Werb Z.ECM signalling:orchestrating cell behaviour and misbehaviour[J].Trends Cell Biol,1998,8:437-441.
  • 2Zhou CF,Ye F,CaD LH,et al.Overexpression of integrin a5p 1 in human hepatocellular carcinoma cell line suppresses cell proliferation in vitro and tumorigenicity in nude mice[J].Mol Cell Biochem,2000,207:49-55.
  • 3Giancotti FG,Ruoslahti E.lntegrin signaling[J].Science,1999,285(5430):1028-1032.
  • 4Haunstetter A,Izumo S.Apoptosis basic mechanisms and implications for cardiovascular disease[J].Circulation Research,1998,82 (11):111-1129.
  • 5Nicholson DW.Caspase structure,proteolytic substrates,and function during apoptotic cell death[J].Cell Death Diff,1999,6:1028-1042.
  • 6Sonoda Y,Matsumoto Y,Funakoshi M,et al.Anti-apoptotic role of focal adhesion kinase (FAK).Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line,HL-60[J].Biol.Chem,2000,275:16309-16315.
  • 7Robertson GS,Crocker SJ,Nichlson DW,et al.Neuroprotion by the inhibition of apoptosis[J].Brain Pathol,2000,10 (2):283-292.
  • 8Chen TA,Yang F,Cole GM,et al.Inhibition of caspase-3-l ike activity reduces glutamate induced cell death in adult rat retina[J].Brain Res,2001,904:177-188.
  • 9Darzynkiewicz Z,Bedner E,Smolewski P,et al.Detection of caspase activation in situ by fluorochrume labeled inhibitors of caspase[J].Methods Mol Boil,2002,203:289-299.
  • 10Frisch SM,Francis H.Disruption of epithelial cell-matrix interactions induces apoptosis[J].Cell Biol,1994,124:619-626.

共引文献1

同被引文献10

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部